Peter Cruz‐Gordillo
-
- PARP inhibition in cancer therapy 2
-
- Glycosylation and Glycoproteins Research 1
- RNA modifications and cancer 1
- Protein Structure and Dynamics 1
- DNA Repair Mechanisms 1
- CRISPR and Genetic Engineering 1
-
- Autophagy in Disease and Therapy 1
-
- Infectious Diseases and Tuberculosis 1
- Co-authors
- Michael J. LeeHannah SchwartzOlivier FédrigoCourtney C. BabbittGregory A. WrayThomas LeeteAdam D. PfefferleLisa Warner
- Partner nations
- United StatesDenmark
In The Last Decade
Peter Cruz‐Gordillo
8 papers receiving 139 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 23
- Oncology 38
- Modeling and Simulation 5
- Biophysics 6
- Molecular Biology 72
Countries citing papers authored by Peter Cruz‐Gordillo
This map shows the geographic impact of Peter Cruz‐Gordillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Cruz‐Gordillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Cruz‐Gordillo more than expected).
Fields of papers citing papers by Peter Cruz‐Gordillo
This network shows the impact of papers produced by Peter Cruz‐Gordillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Cruz‐Gordillo. The network helps show where Peter Cruz‐Gordillo may publish in the future.
Co-authorship network
The 21 scholars most cited alongside Peter Cruz‐Gordillo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 1 | |
| 3 | 2020 | 15 | |
| 4 | 2020 | 26 | |
| 5 | 2019 | 23 | |
| 6 | 2018 | 33 | |
| 7 | 2010 | 25 | |
| 8 | 2010 | 13 |
About Peter Cruz‐Gordillo
Peter Cruz‐Gordillo is a scholar working on Microbiology, Oncology and Molecular Biology, having authored 8 papers that have together received 139 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (2 papers), Glycosylation and Glycoproteins Research (1 paper), Autophagy in Disease and Therapy (1 paper), RNA modifications and cancer (1 paper), Protein Structure and Dynamics (1 paper), Infectious Diseases and Tuberculosis (1 paper), DNA Repair Mechanisms (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Cancer Research (23 citations), Oncology (38 citations) and Modeling and Simulation (5 citations). Peter Cruz‐Gordillo has collaborated with scholars based in United States and Denmark. Frequent co-authors include Michael J. Lee, Hannah Schwartz, Olivier Fédrigo, Courtney C. Babbitt, Gregory A. Wray, Thomas Leete, Adam D. Pfefferle, Lisa Warner, Nicholas W. Harper and Alyssa D. Schwartz. Their work appears in journals such as Nature Chemical Biology, Science Signaling, PLoS ONE, Cancer Research and Molecular Systems Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.